课题基金 / 基金详情

Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo

Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
hnRNP A1 对 c-myc 翻译的调节:在多发性骨髓瘤肿瘤反应中的作用
批准号:
8509516
负责人:
JOSEPH F GERA
金额:
$24.91万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2015-05-31

项目摘要

项目成果

JOSEPH F GERA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long range goal of the proposal is to investigate the mechanism of cap-independent translation of the c-myc protein with the assumption that its cellular function is a key determinant of tumor cell responses, especially for the malignancy multiple myeloma. More specifically, the proposal will elucidate how hnRNP A1 (A1) functions as a trans-acting protein that binds to the internal ribosome entry site (IRES) in the 5' UTR of the c-myc transcript, thus facilitating IRES-dependent translation of myc. Furthermore, it will focus on the ability of Akt and MAPK cascades to regulate this A1 translation-promoting activity, testing effects on the IRES-annealing activity of A1, effects on IRES-ribosome binding and effects on A1/IRES subcellular localization. Multiple myeloma cell lines, primary tumor cells and xenograft models will be used to exploit the insight gained on A1/myc IRES regulatory controls to understand mechanisms of myeloma progression due to IL-6 stimulation and myeloma therapy-resistance when treatment with mTOR inhibitors is attempted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-targeting mTOR and YAP signaling in glioblastoma
Co-targeting mTOR and YAP signaling in glioblastoma
Mechanisms of Resistance to mTOR-Targeted Therapies
Mechanisms of Resistance to mTOR-Targeted Therapies
海外基金